Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
0.1-<1%
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.1-<0.5%
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.1-<0.3% 0.5%< >=5% <5% 0.5%<
EC/CAS
611-341-5/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
>=0.6% 0.06%< <0.0015% >=0.6% 0.06%< >=0.0015%
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
01-2120764690- >=0.0015% <0.0015%
General Information
Version
1.01
Revision date
2024-09-26
Product name
ACRYL-PEN EXTRA SILICONIZED ACRYLIC SEALANT BEYAZ
1.2.1 Relevant identified uses
Adhesives and/or sealants
Manufacturer Name
Bostik SA
Emergency telephone
+353 (01) 8092166, +353 (01) 8092566, +44 (1785) 272650
Icons in SDS
Company Information
company name
Bostik SA
e-mail address of the competent person responsible for the Safety Data Sheet
SDS.box-EU@bostik.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture Classification according to
Hazard statements
EUH208 - Contains 2-methyl-2H-isothiazol-3-one [MIT] & reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1) [C(M)IT/MIT]. May produce an allergic reaction EUH210 - Safety data sheet available on request
2.3 Other hazards
No information available.
PBT Substances
& vPvB The components in this formulation do not meet the criteria for classification as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] This mixture is classified as not hazardous according to regulation (EC) 1272/2008 [CLP]
